Northwestern Medicine scientists used ultrasound to deliver chemo and immunotherapy for glioblastoma, enhancing immune system recognition of cancer cells.
Small doses of doxorubicin with immune checkpoint antibodies reinvigorate immune cells to attack glioblastoma, overcoming immune system deactivation by cancer cells.
[
add
]
[
|
|
...
]